First this tells me that Gates would not have granted CEMI if the Saliva Biomarkers were not available.
Second, with the Johns Hopkins research that must have been done, if biomarkers were created successfully, CEMI must be using them. Where else would they get them?
I can see Gates Foundation bringing companies together to make this all happen.
Early in 2015, Gates granted 500K to Johns Hopkins along with Ceres Nanosciences to create biomarkers that will detect Malaria in saliva .....
Hopkins team will work with biotech firm Ceres Nanosciences on saliva test that could detect malaria parasites in asymptomatic individuals
Researchers at the Johns Hopkins Bloomberg School of Public Health have been awarded a $525,000 grant from the Bill & Melinda Gates Foundation to evaluate a promising technology that detects malaria parasites in saliva before individuals get sick and become carriers of the parasite. The team, part of the Johns Hopkins Malaria Research Institute, will work with the biotech firm Ceres Nanosciences to assess a sampling platform developed by Ceres.
Despite progress in the campaign to eliminate the mosquito-borne illness, malaria still sickens an estimated 200 million people a year and kills an estimated 600,000 of them, mostly children under the age of five. Non-invasive tests that do not require needles and/or lab work -- the way many blood tests do -- and can provide rapid diagnosis are seen as a critical step in reducing first-time malaria cases and blocking transmission by those who have recovered but still carry the parasite. Malaria is most successfully treated when caught early.
Preliminary research suggests there is a new set of malaria biomarkers present in saliva, which could identify a larger population of malaria carriers than previously estimated. The Ceres test uses its Nanotrap® particle technology to sample and enrich saliva to identify the presence of the malaria biomarker. During a six-month evaluation, the Hopkins team will work with Ceres to evaluate whether the biomarker can increase the percentage of asymptomatic carriers of malaria who can be correctly diagnosed.
Now months later, Gates grants Chembio Diagnostics to create the first POC Diagnostic Test for Malaria using saliva. I'm wondering if the saliva biomarkers being used are from Johns Hopkins/Ceres?
Love it, MJ
......Abbott: Strange as it may seem, they give ball players nowadays very peculiar names.
Costello: Funny names?
Abbott: Nicknames, nicknames. Now, on the St. Louis team we have Who's on first, What's on second, I Don't Know is on third--
Costello: That's what I want to find out. I want you to tell me the names of the fellows on the St. Louis team.
Abbott: I'm telling you. Who's on first, What's on second, I Don't Know is on third--
Costello: You know the fellows' names?
Costello: Well, then who's playing first?
Costello: I mean the fellow's name on first base.
Costello: The fellow playin' first base.
Costello: The guy on first base.
Abbott: Who is on first.
Costello: Well, what are you askin' me for?
Abbott: I'm not asking you--I'm telling you. Who is on first.
Costello: I'm asking you--who's on first?
Abbott: That's the man's name.
Costello: That's who's name?
~ ~ ~ ~ ~
Costello: When you pay off the first baseman every month, who gets the money?
Abbott: Every dollar of it. And why not, the man's entitled to it.
Costello: Who is?
Costello: So who gets it?
Abbott: Why shouldn't he? Sometimes his wife comes down and collects it.
Costello: Who's wife?
Abbott: Yes. After all, the man earns it.
Costello: Who does?
Costello: Well, all I'm trying to find out is what's the guy's name on first base?
Abbott: Oh, no, no. What is on second base.
Costello: I'm not asking you who's on second.
Abbott: Who's on first!
I don't know MJ?......I heard that Mo can put away the beer......if it continues to go up......why not.
Say...if patterns hold true...with decreasing volume over the past 5 days....and rising price.....for a stock with so few shares.....its telling me that not many shares are being offered.
Market Maker bid is low but rising....started at 7.05, now 7.15, still no sellers. That should drive bid up...and price up......because no one wants to sell and demand is increasing for this stock.
There will be a consolidation and a drop....but hopefully will stay above the 7.20 mark through or to the cc.
Just my guess.
If above 7.20 can hold, and become resistance.....we will see a ride. Thanks MJ....I will take you up on the beer....two beers.....Yang Black and Tan or Guinness, if you don't mind.
If it goes to 7.30 and holds ...Ill buy.
This ceiling was last tested April/May 2006, but wasn't able to break through. Can it now? I am thinking so. Almost 10 years to the day.
Zika was first seen in Uganda in 1947. It didn't seem to do much to people. It's closely related to dengue virus, which can cause a deadly hemorrhagic fever. But Zika seemed not to cause any symptoms in most people, and at worst a rash and fever in those who did notice anything.
An epidemic in the Pacific Islands in 2013 and 2014 looked different. People noticed the symptoms of rash, fever and achiness much more.
And when Zika hit Brazil last year, people noticed they felt much sicker. Then authorities reported a startling rise in the number of cases of a terrible birth defect called microcephaly, marked by a smaller-than-normal brain and head. Zika's now been found in the brain tissue of fetuses and babies killed by severe birth defects, and they include a range of damage to the brain
The U.S. Centers for Disease Control and Prevention says there's no doubt Zika causes these defects. The World Health Organization says it's pretty clear Zika also causes paralyzing nerve conditions, including Guillain-Barre syndrome and inflammations of the brain and spinal cord.
Question: How fast are the strains mutating? Will CEMI need to and be able to create a test for each strain?
I think we should continue to see CEMI climb as it gets warmer in the US. If case of Zika climb, that will contribute. Rumors of a take over, higher value of the dollar, approval of spending bill for Zika will also contribute. Heaven forbid a Zika epidemic anywhere......
With a straight up steady climb, this looks to me to be someone or institution, accumulating this stock at a steady pace. There is such a limited number of shares (8M), it would not take long for someone to accumulate or a group of individuals, who could choreograph a take over, without needing to report. If one individual, I would suspect that they would have to report soon. Isn't reporting required if more than 5% holdings in a particular stock?
My question is, if someone already holds more than 5%, and they are accumulating more, do they have to report/disclose each purchase of additional shares?
Again, this may be totally ridiculous....but what the heck.
I hear ya MJ. It goes both ways. Congress doesn't submit them because they know OBAMA will veto......plus the first 4 years he had a democratic led congress......so count really isn't a good barometer. Neither work well with each other....like water and fire.....they just don't have the chemistry to try to work together.....but the point is.....CEMI wont see much of any money from Zika in the USA. I might be wrong as CEMI now has a lobby....now called Gates and Allen...(sounds like a stand up comedian act). Revenue is leaning away from USA as it has been for years, also.
It's frustrating. Congress won't budge if proposes by Obama. Obama will veto anything passed by congress. In any case , CEMI business has never really came from the USA. It has historically come from SA. I WOULD NOT EXPECT SIGNIFICANT NA revenue. Grants, yes. Sales no. But sales will come from S America...soon.
Sentiment: Strong Buy
You are correct Mo. Based upon that statement Sperz made (twice), that they would be recognizing Zika revenue in 2016, I think he was telling the investors something. 1) They are confident that they will have a successful test kit for Zika in 2016 and 2) At the point that they have a successful test kit in 2016, they already have a contract that will start payments. I don't think they will be able to get through all the regulatory approvals in 2016 to sell in the US.....but then again ....Brazil just may have committed to fast tracking it (already). Something made Sperz say it twice......That is so unusual for a CEO to commit to revenue in current year for a product that doesn't exist.
Good things are about to happen. Time to start buying this nugget.
Sentiment: Strong Buy